Verapamil Treatment of Hypertrophic Obstructive Cardiomyopathy

  • M. Kaltenbach
  • R. Hopf
  • G. Kober
  • W.-D. Bussmann
  • M. Keller
  • Y. Petersen
Conference paper

Abstract

First described in the last century, HOCM is recognized today in a considerable number of patients. The severity of the disorder varies between severe disablement to a completely asymptomatic clinical picture.

Keywords

Catheter Cardiomyopathy Catecholamine Propranolol Verapamil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Daniels, J. R., Billingham, M. E., Gelbart, A., Bristow, M. R.: Effect of Verapamil and Propranolol on Adriamycin-Induced Cardiomyopathy in Rabbits. 49. Sess. Am. H. Assoc., 1976, Abstr. 70Google Scholar
  2. 2.
    Edwards, R.H.T., Kristinsson, A., Warrell, D.A., Goodwin, J.F.: Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy. Br. Heart J. 32, 219 (1970)PubMedCrossRefGoogle Scholar
  3. 3.
    Fleckenstein, A.: Myokardstoffwechsel und Nekrose. In: Herzinfarkt und Schock. Heilmeyer, L., Holtmeier, H. J. (eds.). Stuttgart: Georg Thieme 1969Google Scholar
  4. 4.
    Gensini, G.G.: Coronary Arteriography. New York: Futura Publishing 1975Google Scholar
  5. 5.
    Goodwin, J.F.: Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet 1970/1, 731CrossRefGoogle Scholar
  6. 6.
    Hubner, P.J.B., Ziady, G.M., Lane, G.K., Hardason, T., Scales, B., Oakley, C.M., Goodwin, J.F.: Double-blind trial of propranolol and practol in hypertrophic cardiomyopathy. Br. Heart J. 35, 1116 (1973)PubMedCrossRefGoogle Scholar
  7. 7.
    Kaltenbach, M., Hopf, R., Keller, M.: Calciumantagonistische Therapie bei hypertrophobstruktiver Kardiomyopathie. Dtsch. med. Wschr. 101, 1284–1287 (1976)PubMedCrossRefGoogle Scholar
  8. 8.
    Kober, G., Spahn, G., Becker, H.-J., Kaltenbach, M.: Weite und Querschnittsfläche der großen, epikardialen Koronararterien bei Herzmuskelhypertrophie. Z. Kardiol. 63, 297–310 (1973)Google Scholar
  9. 9.
    Loogen, F., Krelhaus, W., Kuhn, H.: Verlaufsbeobachtungen der hypertrophischen obstruktiven Myokardiopathie (HOCM). Z. Kardiol. 65, 511–521 (1976)PubMedGoogle Scholar
  10. 10.
    Lossnitzer, K.: Genetic induction of cardiomyopathy. In: Handbuch der experimentellen Pharmakologie. Born, G.V.R., Eichler, O., Farah, A., Herken, H., Welche, A.D. (eds.). Berlin-Heidelberg-New York: Springer-Verlag 1975, Vol. XVI, p. 309Google Scholar
  11. 11.
    Morrow, A.G.: Operative treatment in hypertrophic subaortic techniques, and the results of pre- and postoperative assessments in 83 patients. Circul. 52, 88–102 (1975)Google Scholar
  12. 12.
    Roskamm, H.: Die Kontraktilitätsreserve des gesunden linken Ventrikels bei körperlicher Belastung nach Beta-Rezeptorenblockade. Z. Kreisl.-Forsch. 61, 802 (1972)Google Scholar
  13. 13.
    Rothlin, M., Arbenz, U., Krayenbühl, H.P., Turina, J., Senning, A.: Spätresultate nach Operationen bei muskulärer subvalvulärer Aortenstenose. Z. Kardiol. 65, 501–510 (1976)PubMedGoogle Scholar
  14. 14.
    Stenson, R.E., Flamm, Jr., Harrison, D.C., Hancock, E.W.: Hypertrophie subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy. Am. J. Cardiol. 31 (1973), p. 763–773PubMedCrossRefGoogle Scholar
  15. 15.
    Sowton, E.: Beta-Rezeptorenblocker bei hypertropher Cardiomyopathie. In: Die Beta-Blocker - Gegenwart und Zukunft. Schweizer, W. (ed.). Bern: Huber 1976, p. 239Google Scholar
  16. 16.
    Witzke, D.J., Kaye, M.P.: Hypertrophie Cardiomyopathy Induced by Administration of Nerve Growth Factor. 49. Sess. Am. Assoc. 1976, Abstr. 344Google Scholar
  17. 17.
    Wrogemann, K., Pena, S.D.J.: Mitochondrial calcium overload. A general mechanism for cell-necrosis in muscle diseases. Lancet 1976/1, 672PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1978

Authors and Affiliations

  • M. Kaltenbach
  • R. Hopf
  • G. Kober
  • W.-D. Bussmann
  • M. Keller
  • Y. Petersen

There are no affiliations available

Personalised recommendations